Latest / European Society for Vascular Surgery

Drug eluting technology: is it dangerous and does it even work? A look at the timeline of evidence with Professors Behrendt and Roy
Prof. Christian Behrendt (head of the German research association) and Prof. Joy Roy
(Karolinska Institute) take us on a look back chronologically at the journey
Paclitaxel has taken us on, from the original mortality scare to landmark trials, we follow
the twists and turns of the evidence.
We ask if safety is only half the story and whether it makes sense to judge every
drug-coated balloon and stent as one big, paclitaxel-coated family, what the emerging
Limus technologies might bring to the table, and whether industry influence has helped
shape a debate in which the stakes are anything but…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.